Equine diseases encompass a wide range of health conditions that can affect horses, including infectious diseases, metabolic disorders, and genetic conditions. These diseases can impact the overall health, performance, and well-being of horses. Common equine diseases include equine influenza, equine herpesvirus, laminitis, and equine metabolic syndrome. Diagnosis and management of these diseases often require a combination of clinical evaluation, laboratory testing, and appropriate treatment strategies. This page gathers peer-reviewed research studies and scholarly articles that explore the etiology, pathophysiology, diagnosis, and treatment options for various equine diseases, providing valuable insights for veterinarians and researchers in the field.
Swierstra EE, Gebauer MR, Pickett BW.The cycle of the seminiferous epithelium of the stallion was
divided into eight stages, using as criteria the presence of meiotic divi-
sions, shape of the spermatid nuclei and location of spermatids with
elongated nuclei in the tubule. The mean frequencies ofstages 1 to 8 were
16\m=.\9, 14\m=.\9, 3\m=.\2, 15\m=.\8, 7\m=.\4, 13\m=.\5, 12\m=.\6 and 15\m=.\7%, respectively. The
duration of one cycle of the seminiferous epithelium was 12\m=.\2 days
(S.E.\m=+-\0\m=.\1) as determined by injecting a single dose of 700 \g=m\Ciof
[3H]thymidine into each spermatic artery of six stallions and rem...
Nakajima H, Yoshino T, Ushimi C.Equine infectious anemia virus was purified from infected horse serum samples. Electron microscope observation on negatively stained preparations of purified virus showed roughly spherical particles sized between 100 and 200 nm in diameter. In disrupted particles, an envelope was visible but no internal structure could be resolved. Since the purified virus fraction had a strong antigenic activity to antiserum in immunodiffusion reaction, these particles are thought to be the causative virus of equine infectious anemia.
Millar R, Francis J.Day (1939) recorded 95% fertility in wild
ponies, but in heavy horses it was only 52%
and in thoroughbreds 68%. Variation of fertility was stated by Anderson (1922) was not due
to disease or physiological malfunction, but to
highly artificial methods of mating. In New
Zealand, Bain (1948) recorded the fertility of
mares in 1944 as 61%. MahaiIey (1950) made
a survey in Western Australia and found fertility
rates which varied from 17% to 50% before
veterinary assistance was obtained.
An article in the British Racehorse (Anon
1949) revealed no evidence of any progress in
the control o...
Bampidis V, Azimonti G, Bastos ML, Christensen H, Durjava M, Kouba M, López-Alonso M, López Puente S, Marcon F, Mayo B, Pechová A, Petkova M....Following a request from the European Commission, EFSA was asked to deliver a scientific opinion on the safety and efficacy of an essential oil from the seeds of Houtt. (nutmeg oil), when used as a sensory additive in feed and water for drinking for all animal species. The additive contains myristicin (up to 12%), safrole (2.30%), elemicin (0.40%) and methyleugenol (0.33%). For long-living and reproductive animals, the Panel on Additives and Products or Substances used in Animal Feed (FEEDAP) considered of low concern the use of the additive in complete feed at 0.2 mg/kg for laying hens and...
Dik KJ.The radiological interpretation of periosteal new bone formation in the horse induced by trauma is described and illustrated by some casereports. The better the margins of the new bone can be defined the lesser the activity. The greater the density of the new bone, the longer the duration of time since injury.
Marchenko VA, Khalikov SS, Biryukov IV, Efremova EA, Ilyin MM, Sazmand A.This study aimed to develop new complex preparations of ivermectin, niclosamide and albendazole based on solid-phase mechanochemical technology, and to evaluate their efficacy against equine nematodosis and cestodosis. Unassigned: Novel formulation of antiparasitic paste were prepared using joint mechano-chemical treatment of ivermectin (0.2 mg/kg bodyweight; BW), niclosamide (10 mg/kg BW) and albendazole (3, 5, 10 mg/kg BW) substances with polyvinylpyrrolidone and arabinogalactan. For the evaluation of activity of different doses of formulations against gastrointestinal tract helminths a tota...
